Global CRM Reporting Unit — Net Sales
Boston Scientific Global CRM Reporting Unit — Net Sales increased by 1.4% to $586.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.4%, from $567.00M to $586.00M. Over 4 years (FY 2021 to FY 2025), Global CRM Reporting Unit — Net Sales shows an upward trend with a 3.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests strong market adoption of the company's cardiac rhythm devices and successful clinical penetration, while a decrease may indicate increased competition, pricing pressure, or a shift in clinical treatment guidelines.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and systems designed to monitor and...
Peer comparison
Comparable to revenue segments for cardiac rhythm management or electrophysiology divisions at major medical device competitors like Medtronic or Abbott Laboratories.
bsx_segment_cardiac_rhythm_management_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $524.00M | $512.00M | $514.00M | $519.00M | $541.00M | $519.00M | $521.00M | $548.00M | $566.00M | $552.00M | $552.00M | $575.00M | $576.00M | $561.00M | $567.00M | $578.00M | $590.00M | $578.00M | $586.00M |
| QoQ Change | — | -2.3% | +0.4% | +1.0% | +4.2% | -4.1% | +0.4% | +5.2% | +3.3% | -2.5% | +0.0% | +4.2% | +0.2% | -2.6% | +1.1% | +1.9% | +2.1% | -2.0% | +1.4% |
| YoY Change | — | — | — | — | +3.2% | +1.4% | +1.4% | +5.6% | +4.6% | +6.4% | +6.0% | +4.9% | +1.8% | +1.6% | +2.7% | +0.5% | +2.4% | +3.0% | +3.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's global crm reporting unit — net sales?
- Boston Scientific (BSX) reported global crm reporting unit — net sales of $586.00M in Q4 2025.
- How has Boston Scientific's global crm reporting unit — net sales changed year-over-year?
- Boston Scientific's global crm reporting unit — net sales increased by 3.4% year-over-year, from $567.00M to $586.00M.
- What is the long-term trend for Boston Scientific's global crm reporting unit — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's global crm reporting unit — net sales has grown at a 3.7% compound annual growth rate (CAGR), from $2.02B to $2.33B.
- What does global crm reporting unit — net sales mean?
- Total revenue generated from the sale of heart rhythm management medical devices and related technologies.